We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to CytoDyn About COVID-19 Claims in Video Interview
FDA Issues Warning Letter to CytoDyn About COVID-19 Claims in Video Interview
FDA’s Office of Prescription Drug Promotion (OPDP) has issued a warning letter to precision medicine developer CytoDyn about a video interview found on the company’s corporate website.